Century Therapeutics (IPSC) Non-cash Items (2021 - 2026)

Century Therapeutics (IPSC) has 6 years of Non-cash Items data on file, last reported at $6.3 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $6.3 million, up 11.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 11.16% YoY), and the FY2025 annual result was $6.1 million, up 22.66% from the prior year.
• Non-cash Items improved to $6.3 million in Q1 2026 per IPSC's latest filing, from $6.1 million in the prior quarter.
• Over five years, Non-cash Items peaked at $38.4 million in Q1 2023 and troughed at $3.2 million in Q4 2022.
• A 5-year average of $14.4 million and a median of $9.4 million in 2025 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items surged 1315.33% in 2022, then sank 69.49% in 2025.
• A 5-year view of Non-cash Items shows it stood at $3.2 million in 2022, then increased by 22.57% to $3.9 million in 2023, then rose by 26.96% to $5.0 million in 2024, then increased by 22.66% to $6.1 million in 2025, then increased by 2.44% to $6.3 million in 2026.
• Business Quant data shows IPSC's Non-cash Items at $6.3 million in Q1 2026, $6.1 million in Q4 2025, and $9.4 million in Q3 2025.